MicrobiologybioRxivPreprint
Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus
Z. Ao, M. Jing Ouyang, T. A. Olukitibi…·X. Yao
This study develops and tests a bivalent rVSV vaccine targeting SARS-CoV-2 Delta and influenza, showing strong immune responses and protection in animal models.
DOI 10.1101/2021.12.14.472657